Status:
NOT_YET_RECRUITING
Cervical Cytology DNA Methylation for Cervical Cancer Screening
Lead Sponsor:
Lei Li
Conditions:
Cervical Cancer
DNA Methylation
Eligibility:
FEMALE
18+ years
Brief Summary
Cervical cancer represents one of the foremost causes of cancer-related morbidity and mortality among women worldwide. Given the current limitations, such as the low specificity of human papillomaviru...
Eligibility Criteria
Inclusion
- Aged 18 years or older
- With uterine cervix intact
- Given consents to participate the study
- With detailed follow-up outcomes
Exclusion
- Not meeting all of the inclusion criteria
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT06557954
Start Date
September 1 2024
End Date
October 1 2026
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China